In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Isabella LinDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.ORCID 0000-0002-7102-6879 Michael Sigfrid S ReyesDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Abigail S KrallDepartment of Biological Chemistry, University of California Los Angeles, Los Angeles, California.
Neerja VashistDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.ORCID 0000-0002-1887-270X Suzanne SarkissianDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Nedas MatulionisDepartment of Biological Chemistry, University of California Los Angeles, Los Angeles, California.ORCID 0000-0001-7624-3090 Aileen NingDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Linsey StilesDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.ORCID 0000-0002-1514-458X Bianca E RussellDepartment of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.ORCID 0000-0003-3934-9800 Paul Mark B MedinaBiological Models Laboratory, Department of Biochemistry and Molecular Biology, College of Medicine, University of the Philippines Manila.
Heather R ChristofkDepartment of Biological Chemistry, University of California Los Angeles, Los Angeles, California.ORCID 0000-0002-8662-4425 Valerie A ArboledaDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.ORCID 0000-0002-9687-9122 Funding
UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9MUCLA Medical Genetics Training ProgramT32GM008243 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Julian Martinez-Agosto, STANLEY F. NELSON · 1987 to 2026
$6.8MUCLA-Caltech Medical Scientist Training ProgramT32GM152342 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Olujimi A Ajijola, David Wayne Dawson · 2024 to 2026
$5.3MDevelopment of high-throughput cellular models for ASXL1-related diseasesR03TR004645 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARBOLEDA, VALERIE A · 2023 to 2023
$157kNCATS NIH HHS R03 TR004645NIGMS NIH HHS T32 GM008042NIGMS NIH HHS T32 GM008243NIGMS NIH HHS T32 GM152342
6 · The paper itselfAbstract
Bohring-Opitz syndrome (BOS, OMIM#605309) is a rare neurodevelopmental disorder caused by heterozygous and truncating variants in
Identifiers
PMID42523271
PMCPMC13404655
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390